Clinical trial
RECOVER-AUTONOMIC (IVIG): Randomized Trial of the Effect of IVIG Versus Placebo on Long COVID Symptoms
NCT06305793 is registered in ClinicalTrials.gov with Kanecia Obie Zimmerman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RECOVER-AUTONOMIC (IVIG): Randomized Trial of the Effect of IVIG Versus Placebo on Long COVID Symptoms
- Lead sponsor
- Kanecia Obie Zimmerman
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 8, 2024
- Completion date
- June 22, 2026
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
long coronavirus disease 2019 (covid19), long covid, long covid-19